News
The highly common herpes strain, also called varicella-zoster virus (VZV), can cause chickenpox in childhood and later ...
Record HEPLISAV-B® first quarter net product revenue of $65 million, representing 36% year-over-year growth Top-line results in Part 1 of Phase 1/2 shingles vaccine ...
New research looks at the emotional and physical repercussions of having your brain scanned for early signs of dementia.
IT may feel too early to talk about hay fever, but it is actually the perfect time. To avoid getting floored by symptoms as ...
THE shingles vaccine lowers the risk of a heart attack or stroke for up to eight years, new research shows. People given a ...
GSK’s dealmaking will be “cautious and disciplined” under the current trade war, but the pharma will focus on looking for ...
WASHINGTON—A vaccine to fight dementia? It turns out there may already be one – shots that prevent painful shingles also appear to protect aging brains. A new study found shingles vaccination cut ...
GSK posted higher profit as sales for its specialty treatments for HIV, cancer and asthma beat expectations, offsetting lower ...
GSK posted higher profit as sales for its specialty treatments including HIV, cancer and asthma beat expectations, offsetting lower vaccine sales on weak demand in the U.S.
A routine vaccination recommended for adults over 50 might be doing double duty in protecting our health. Recent research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results